Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virologic Failure”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableStudy completedNCT00886990
What this trial is testing

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Who this might be right for
HIV InfectionHIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 240
Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Post-approval studies (Phase 4)Ended earlyNCT00356616
What this trial is testing

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 24
Not applicableStudy completedNCT00678600
What this trial is testing

Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,011
Not applicableStudy completedNCT00028366
What this trial is testing

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Not applicableStudy completedNCT01801618
What this trial is testing

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

Who this might be right for
HIV
ANRS, Emerging Infectious Diseases 15,001,351
Large-scale testing (Phase 3)Temporarily pausedNCT00353327
What this trial is testing

Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 30
Testing effectiveness (Phase 2)UnknownNCT05082727
What this trial is testing

Safety and Efficacy of Softgel KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR)

Who this might be right for
COVID-19
Sao Thai Duong Joint Stock Company 60
Testing effectiveness (Phase 2)Study completedNCT02232581
What this trial is testing

Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure

Who this might be right for
HIV Infections
Boehringer Ingelheim 72
Not applicableUnknownNCT05202613
What this trial is testing

Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients (DORAge).

Who this might be right for
HIV
University of Roma La Sapienza 90
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Not applicableUnknownNCT04593979
What this trial is testing

ANRS 12406 EvvA Study

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 289
Not applicableStudy completedNCT01805427
What this trial is testing

Antiretroviral Therapy and Extreme Weight

Who this might be right for
HIV Infection
Hopital Lariboisière 140
Not applicableUnknownNCT05322083
What this trial is testing

HIV A6 Genome In ART Unsuccessful Patients On DOR

Who this might be right for
Virus-HIV
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Not applicableEnded earlyNCT00937729
What this trial is testing

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Who this might be right for
HIV1 InfectionHIV Infections
University Hospital, Rouen 4
Large-scale testing (Phase 3)UnknownNCT02646111
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures

Who this might be right for
Hepatitis C
Tel-Aviv Sourasky Medical Center 120
Not applicableLooking for participantsNCT05373758
What this trial is testing

Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa

Who this might be right for
HIV InfectionsAIDSVirologic Failure
Massachusetts General Hospital 648
Not applicableUnknownNCT03557021
What this trial is testing

Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania

Who this might be right for
HIV Drug Resistance
Medical Mission Institute, Germany 1,250
Next Page